August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Christine Hodgdon: CHLOE study enrolling participants with HER2+ oligometastatic breast cancer
Mar 16, 2025, 12:18

Christine Hodgdon: CHLOE study enrolling participants with HER2+ oligometastatic breast cancer

Christine Hodgdon, Co-founder of GRASP, shared a post on X:

“If you are living with HER2+ oligometastatic breast cancer (oligo = limited of mets), you may be eligible to participate in the CHLOE study, Yale Cancer Center.

Individuals (US and international) can now self refer!

Read more.”

More posts featuring Christine Hodgdon.